Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Obes (Lond) ; 46(1): 153-161, 2022 01.
Article in English | MEDLINE | ID: mdl-34564707

ABSTRACT

BACKGROUND: Bioactive dietary constituents activating Transient receptor potential (TRP) channels have emerged as promising candidates for the prevention of metabolic disorders. OBJECTIVE: The present study is an attempt to evaluate anti-obesity potential of a dietary TRP-based tri-agonist, combination of sub-effective doses of capsaicin (TRPV1 agonist), menthol (TRPM8 agonist), and cinnamaldehyde (TRPA1 agonist) in high-fat diet (HFD)-fed mice. DESIGN: Male C57BL/6 J mice divided into three groups (n = 8), were fed on normal pellet diet (NPD), or high-fat diet (HFD) (60% energy by fat) and HFD + CB (combination of capsaicin 0.4 mg/Kg, menthol 20 mg/Kg, and cinnamaldehyde 2 mg/Kg; p.o) for 12 weeks. Effects on HFD-induced weight gain, biochemical, histological and genomic changes in the WAT, BAT, liver and hypothalamus tissues were studied. RESULTS: Administration of tri-agonist prevented HFD-induced increase in weight gain, improved altered morphometric parameters, glucose homeostasis, and adipose tissue hypertrophy. Tri-agonist supplementation was found to induce browning of white adipose tissue and promote brown adipose tissue activation. Enhanced glucose utilization and prevention of lipid accumulation and insulin resistance in the liver was observed in mice supplemented with a tri-agonist. CONCLUSION: The present work provides evidence that the new approach based on combination of sub-effective doses of TRP channel agonists (TRI-AGONIST) can be employed to develop concept-based functional food for therapeutic and preventive strategies against HFD-associated pathological complications.


Subject(s)
Energy Metabolism/drug effects , Transient Receptor Potential Channels/agonists , Acrolein/administration & dosage , Acrolein/analogs & derivatives , Acrolein/therapeutic use , Animals , Capsaicin/administration & dosage , Capsaicin/therapeutic use , Diet, High-Fat/adverse effects , Diet, High-Fat/methods , Disease Models, Animal , Menthol/administration & dosage , Menthol/therapeutic use , Mice , Mice, Inbred C57BL/growth & development , Mice, Inbred C57BL/metabolism , Phenotype , Transient Receptor Potential Channels/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL